Core Viewpoint - A class action securities lawsuit has been filed against Perrigo Company plc, alleging securities fraud that affected investors between February 27, 2023, and November 4, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Perrigo's acquisition of the infant formula business from Nestlé was significantly underinvested in maintenance and operational improvements [2]. - It is alleged that Perrigo needed to incur substantial capital and operational expenditures beyond previously stated cost estimates to address issues in the infant formula business [2]. - The complaint points out significant manufacturing deficiencies in the facility related to the infant formula business [2]. - As a result of these issues, Perrigo's financial results, including earnings and cash flow, were reportedly overstated [2]. - The positive statements made by the defendants regarding the Company's business and prospects were claimed to be materially misleading and lacked a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses during the specified timeframe have until January 16, 2026, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4]. - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the United States [4].

Core Viewpoint - aTyr Pharma, Inc. is facing a class action securities lawsuit due to alleged securities fraud related to misleading statements about the efficacy of its drug Efzofitimod, which led to significant stock price decline [1][2]. Group 1: Lawsuit Details - The lawsuit aims to recover losses for aTyr investors affected by alleged securities fraud between November 7, 2024, and September 12, 2025 [1]. - Defendants allegedly made positive statements about Efzofitimod while concealing adverse facts regarding its efficacy, particularly its ability to allow patients to taper steroid usage [2]. - The truth about the drug's performance was revealed on September 15, 2025, when aTyr announced that the EFZO-FIT study did not meet its primary endpoint, resulting in an 83.2% decline in stock price from $6.03 to $1.02 per share in one day [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the relevant timeframe have until December 8, 2025, to request appointment as lead plaintiff, although participation does not require this role [3]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [3]. Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].

Core Viewpoint - Marex Group plc is facing a class action securities lawsuit due to alleged securities fraud that occurred between May 16, 2024, and August 5, 2025, which has adversely affected investors [1][2] Group 1: Lawsuit Details - The lawsuit claims that Marex Group plc made false statements and concealed information regarding the improper inflation of cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [2] - As a result of these actions, the positive statements made by the defendants about the Company's business and prospects were materially false and misleading [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 8, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record, having secured hundreds of millions of dollars for shareholders over the past 20 years and is recognized as one of the top securities litigation firms in the United States [4]

Core Viewpoint - A class action securities lawsuit has been filed against Freeport-McMoRan Inc. alleging securities fraud that affected investors between February 15, 2022, and September 24, 2025 [1][2] Group 1: Allegations - The lawsuit claims that Freeport-McMoRan did not ensure adequate safety at the Grasberg Block Cave mine in Indonesia [2] - It is alleged that the lack of safety measures posed a heightened risk that could foreseeably lead to worker fatalities [2] - The complaint states that these safety issues resulted in undisclosed regulatory, litigation, and reputational risks [2] - As a consequence, statements made by the defendants regarding Freeport-McMoRan's business and operations were materially false and misleading [2] Group 2: Legal Process - Investors who suffered losses during the specified timeframe have until January 12, 2026, to request appointment as lead plaintiff [3] - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3] Group 3: Firm Background - Levi & Korsinsky has a history of securing hundreds of millions of dollars for shareholders and has extensive expertise in complex securities litigation [4] - The firm has been recognized in ISS Securities Class Action Services' Top 50 Report for seven consecutive years as one of the leading securities litigation firms in the U.S. [4]

Core Viewpoint - Inspire Medical Systems, Inc. is facing a class action lawsuit due to alleged securities fraud related to the poor launch of its new product, Inspire V, which was marked by significant operational failures and misrepresentations to investors [1][2]. Group 1: Lawsuit Details - The class action lawsuit seeks to recover losses for investors affected by alleged securities fraud between August 6, 2024, and August 4, 2025 [1]. - The complaint alleges that the launch of Inspire V was unsuccessful due to poor demand, with providers holding excess inventory and being hesitant to adopt the new treatment [2]. - Defendants are accused of making false statements regarding the successful launch of Inspire V, while failing to complete essential tasks such as training for treatment center customers and setting up necessary IT systems [2]. Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until January 5, 2026, to request appointment as lead plaintiff, although participation in any recovery does not require serving as lead plaintiff [3]. - Class members may be entitled to compensation without incurring any out-of-pocket costs or fees [3]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing significant settlements for shareholders and is recognized as one of the top securities litigation firms in the United States [4]. - The firm has over 20 years of experience in complex securities litigation and a dedicated team of more than 70 employees [4].

San Diego, California--(Newsfile Corp. - November 25, 2025) - The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Six Flags Entertainment Corporation f/k/a CopperSteel HoldCo, Inc. (NYSE: FUN) common stock pursuant or traceable to the company's registration statement and prospectus issued in connection with the July 1, 2024 merger of legacy Six Flags Entertainment Corporation ("Legacy Six Flags") with Cedar Fair, L.P. ("Cedar Fair"), and their subsidiaries and affilia ...

Accessibility StatementSkip Navigation SAN DIEGO, Nov. 25, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of StubHub Holdings, Inc. (NYSE: STUB) common stock pursuant and/or traceable to StubHub's offering documents issued in connection with StubHub's September 17, 2025 initial public offering (the "IPO"), have until January 23, 2026 to seek appointment as lead plaintiff of the StubHub class action lawsuit. Captioned Salabaj v. StubHub Holdings, Inc., No. 25-cv ...

SAN DIEGO, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Firefly Aerospace Inc. (NASDAQ: FLY): (i) securities between August 7, 2025 and September 29, 2025, all dates inclusive (the “Class Period”); and/or (ii) common stock pursuant and/or traceable to Firefly Aerospace’s offering documents issued in connection with Firefly Aerospace’s August 7, 2025 initial public offering (the “IPO”), have until January 12, 2026 to seek appointment as lead pla ...

Core Viewpoint - Investors in Perrigo Company plc have the opportunity to lead a securities fraud class action lawsuit due to undisclosed operational issues and financial misstatements related to the company's infant formula business [1][2]. Summary by Sections Lawsuit Details - The lawsuit alleges that from February 27, 2023, to November 4, 2025, Perrigo failed to disclose significant underinvestment in the acquired infant formula business from Nestlé, which affected maintenance and operational improvements [2]. - It is claimed that Perrigo needed to incur substantial capital and operational expenditures beyond previously stated cost estimates to address issues in the infant formula business [2]. - The complaint highlights significant manufacturing deficiencies in the infant formula facility, leading to overstated financial results, including earnings and cash flow [2]. - As a result of these issues, the positive statements made by Perrigo regarding its business operations and prospects were materially misleading [2]. Participation Information - Investors who suffered losses related to Perrigo are encouraged to participate in the ongoing securities fraud lawsuit, with a lead plaintiff deadline set for January 16, 2026 [2][3]. - Interested parties can contact the Law Offices of Frank R. Cruz for more information or to participate in the lawsuit [3][4].

LOS ANGELES, Nov. 25, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises StubHub Holdings, Inc., (“StubHub" or the "Company") (NYSE: STUB) investors that the firm has initiated an investigation into possible securities fraud, and may file a class action on behalf of investors.  Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 844-767-8529 or email: lesley@portnoylaw.com, to discuss their legal rights, or join the case via https://portnoylaw.com/stubhub-holdings-inc. The Portnoy La ...